Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Hepatic radioembolization as a true single-session treatment.

van den Hoven AF, Prince JF, van den Bosch MA, Lam MG.

J Vasc Interv Radiol. 2014 Jul;25(7):1143-4. doi: 10.1016/j.jvir.2014.01.037. No abstract available.

PMID:
24968730
2.

Reply to "hepatic radioembolization as a true single-session treatment".

Gates V, Salem R.

J Vasc Interv Radiol. 2014 Jul;25(7):1144-6. doi: 10.1016/j.jvir.2014.02.011. No abstract available.

PMID:
24968731
3.

Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres.

Hamoui N, Minocha J, Memon K, Sato K, Ryu R, Salem R, Lewandowski RJ.

J Vasc Interv Radiol. 2013 Nov;24(11):1743-5. doi: 10.1016/j.jvir.2013.07.011. No abstract available.

PMID:
24160828
4.

Outpatient single-session yttrium-90 glass microsphere radioembolization.

Gates VL, Marshall KG, Salzig K, Williams M, Lewandowski RJ, Salem R.

J Vasc Interv Radiol. 2014 Feb;25(2):266-70. doi: 10.1016/j.jvir.2013.11.005. Epub 2013 Dec 12.

PMID:
24332243
5.

Hepatic yttrium-90 radioembolization for metastatic melanoma: a single-center experience.

Memon K, Kuzel TM, Vouche M, Atassi R, Lewandowski RJ, Salem R.

Melanoma Res. 2014 Jun;24(3):244-51. doi: 10.1097/CMR.0000000000000051.

PMID:
24638152
6.

Direct hepatic artery puncture for transarterial therapy in liver cancer.

Yu M, Lewandowski RJ, Ibrahim S, Riaz A, Ryu RK, Benito A, Alonso-Burgos A, Bilbao JI, Salem R.

J Vasc Interv Radiol. 2010 Mar;21(3):394-9. doi: 10.1016/j.jvir.2009.11.003. Epub 2010 Jan 22.

PMID:
20097091
7.

Unexpected ischemic complication after proximal coil embolization of a replaced left hepatic artery before yttrium-90 radioembolization.

Maleux G, Wolter P, Vanslembrouck R, Deroose C.

J Vasc Interv Radiol. 2013 Nov;24(11):1745-7. doi: 10.1016/j.jvir.2013.04.026. No abstract available.

PMID:
24160829
8.

Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.

Burgmans MC, Kao YH, Irani FG, Dames EL, Teo TK, Goh AS, Chow PK, Tay KH, Lo RH.

J Vasc Interv Radiol. 2012 Oct;23(10):1294-301. doi: 10.1016/j.jvir.2012.07.009. Epub 2012 Aug 24.

PMID:
22922039
9.

Yttrium-90 Radioembolization for Breast Cancer Liver Metastases.

Gordon AC, Salem R, Lewandowski RJ.

J Vasc Interv Radiol. 2016 Sep;27(9):1316-1319. doi: 10.1016/j.jvir.2016.06.016. No abstract available.

PMID:
27566423
10.

Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: are contact restrictions necessary?

McCann JW, Larkin AM, Martino LJ, Eschelman DJ, Gonsalves CF, Brown DB.

J Vasc Interv Radiol. 2012 May;23(5):661-7. doi: 10.1016/j.jvir.2012.01.070. Epub 2012 Mar 21.

PMID:
22440592
11.

Yttrium-90 radioembolization in the management of liver malignancies.

Riaz A, Kulik LM, Mulcahy MF, Lewandowski RJ, Salem R.

Semin Oncol. 2010 Apr;37(2):94-101. doi: 10.1053/j.seminoncol.2010.03.006. Review.

PMID:
20494701
12.
13.

The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.

Rhee TK, Omary RA, Gates V, Mounajjed T, Larson AC, Barakat O, Sato KT, Mulcahy M, Gordon S, Lewandowski RJ, Salem R.

J Vasc Interv Radiol. 2005 Aug;16(8):1085-91.

PMID:
16105920
14.

Can C-arm cone-beam CT detect a micro-embolic effect after TheraSphere radioembolization of neuroendocrine and carcinoid liver metastasis?

Pellerin O, Lin M, Bhagat N, Shao W, Geschwind JF.

Cancer Biother Radiopharm. 2013 Jul-Aug;28(6):459-65.

15.

[Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].

Antoch G, Mueller SP, Hamami M, Heusner TA, Ertle J, Hilgard P, Forsting M, Bockisch A.

Rofo. 2010 Aug;182(8):660-70. doi: 10.1055/s-0029-1245380. Epub 2010 Apr 19. Review. German.

PMID:
20405369
16.

Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors.

Riaz A, Lewandowski RJ, Kulik L, Salem R.

Q J Nucl Med Mol Imaging. 2009 Jun;53(3):311-6. Review.

17.

Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.

Herzer K, Müller S, Antoch G, Hilgard P.

Minerva Gastroenterol Dietol. 2011 Sep;57(3):287-98. Review.

PMID:
21769078
18.

Leberradioembolisation: Inzidenz und Risikofaktoren früher Blutflussstauungen.

Manych M.

Rofo. 2017 Jan;188(1):15. doi: 10.1055/s-0042-120170. Epub 2017 Jan 9. German. No abstract available.

PMID:
28068736
19.

Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.

Sangro B, Bilbao JI, Boan J, Martinez-Cuesta A, Benito A, Rodriguez J, Panizo A, Gil B, Inarrairaegui M, Herrero I, Quiroga J, Prieto J.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):792-800. Epub 2006 Aug 14.

PMID:
16904840
20.

Superselective yttrium-90 radioembolization for hepatocellular carcinoma in high-risk cases: another tool in the toolbox.

Brown KT.

J Vasc Interv Radiol. 2014 Jul;25(7):1073-4. doi: 10.1016/j.jvir.2014.04.008. No abstract available.

PMID:
24968727

Supplemental Content

Support Center